NFYC: A Protein Regulator of Gene Expression and Potential Drug Target

Target Name: NFYC

NCBI ID: G4802

NFYC

NFYC: A Protein Regulator of Gene Expression and Potential Drug Target

Nuclear transcription factor Y (NFYC) is a key regulator of gene expression and has been involved in various cellular processes. The NFYC subunit gamma is isoform 6, which has been shown to play a crucial role in the regulation of gene expression.NFYC is a protein that contains multiple domains, including a N-terminal transmembrane domain, a T-loop domain, a variable region, and a C-terminal DNA-binding domain. The N-terminal domain is responsible for the formation of a complex with the DNA , while the T-loop domain and variable region are involved in the regulation of gene expression.

NFYC has been shown to play a role in various cellular processes, including cell growth, differentiation, and response to stimuli. For example, NFYC has been shown to play a role in the regulation of cell growth and has been shown to be involved in the regulation of cell cycle progression. Additionally, NFYC has also been shown to play a role in the regulation of differentiation and has been shown to be involved in the regulation of stem cell proliferation.

The NFYC subunit gamma isoform 6 has also been shown to play a role in the regulation of gene expression. Studies have shown that the N-terminal domain of NFYC is involved in the formation of a complex with DNA and has been shown to play a role in the regulation of gene expression. Additionally, the T-loop domain and variable region of NFYC have also been shown to play a role in the regulation of gene expression.

As a result of its involvement in the regulation of gene expression, NFYC has been considered as a potential drug target or biomarker.NFYC has been shown to play a role in the regulation of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, NFYC has been shown to play a role in the regulation of cancer cell growth and has been shown to be involved in the regulation of neurodegenerative diseases.

In addition to its potential as a drug target or biomarker, NFYC also has potential as a therapeutic agent. NFYC has been shown to play a role in the regulation of cellular processes and has been shown to have potential as a therapeutic agent. For example, NFYC has been shown to play a role in the regulation of stem cell proliferation and has been shown to have potential as a therapeutic agent for the treatment of cancer.

Conclusion

In conclusion, NFYC is a protein that contains multiple domains and has been shown to play a role in the regulation of gene expression. The N-terminal domain, T-loop domain, and variable region of NFYC have been shown to play a role in the regulation of gene expression and have been shown to be involved in various cellular processes. Additionally, NFYC has been shown to play a role in the regulation of cancer, neurodegenerative diseases, and autoimmune diseases. As a result of its involvement in these processes, NFYC has been considered as a potential drug target or biomarker. With its potential as a therapeutic agent, NFYC has the potential to be used in the treatment of a wide range of diseases.

Protein Name: Nuclear Transcription Factor Y Subunit Gamma

Functions: Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'-CCAAT-3' box motif found in the promoters of its target genes. NF-Y can function as both an activator and a repressor, depending on its interacting cofactors

The "NFYC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NFYC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets